Amundi Private Equity Funds is a global asset management firm headquartered in Paris. They offer retail, institutional and corporate clients with investment strategies based on their needs, outcomes and risk profiles. In November 2015, Amundi was listed on the Euronext Paris exchange. Amundi has €1.563 trillion in assets under management.
Amundi Private Equity Funds has invested in Bee Ware, METRIXWARE, Global Imaging Online, McPhy, Envie de Fraises, Genticel, EspaceMax, Biosystems International, Arterial Remodeling, Netaplan, En Voiture Simone, MiiMOSA, Crosscall and Simplon.co.
A biotechnology company developing molecular diagnostic tests for autism and oncology.